Stericycle (SRCL)
(Delayed Data from NSDQ)
$46.31 USD
-0.20 (-0.43%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $46.33 +0.02 (0.04%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$46.31 USD
-0.20 (-0.43%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $46.33 +0.02 (0.04%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth A Momentum B VGM
Zacks News
Stericycle (SRCL) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 13.95% and 1.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Stericycle (SRCL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Stericycle (SRCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stericycle (SRCL) Stock Drops 3% Since Q4 Earnings Release
by Zacks Equity Research
Stericycle's (SRCL) fourth-quarter 2022 earnings and revenues increase year over year.
Stericycle (SRCL) Matches Q4 Earnings Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 0% and 3.94%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Stericycle (SRCL) Gains 19% in the Past 3 Months: Here's How
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships, most of which include long-term contracts ranging from three to five years.
Why You Should Retain Stericycle (SRCL) in Your Portfolio Now
by Zacks Equity Research
Stericycle (SRCL) is currently benefiting from its comprehensive multiyear Business Transformation as well as solid liquidity.
Why You Should Retain Stericycle (SRCL) in Your Portfolio Now
by Zacks Equity Research
Stericycle (SRCL) is being aided by a complete multiyear Business Transformation and a solid cash position.
Stericycle (SRCL) Stock Rises 6.6% Since Q3 Earnings Beat
by Zacks Equity Research
Stericycle's (SRCL) third-quarter 2022 earnings and revenues increase year over year.
Stericycle (SRCL) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 10.17% and 2.99%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
GFL Environmental Inc. (GFL) Q3 Earnings Meet Estimates
by Zacks Equity Research
GFL Environmental Inc. (GFL) delivered earnings and revenue surprises of 0% and 11.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Stericycle (SRCL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Stericycle (SRCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reasons to Retain Stericycle (SRCL) Stock in Your Portfolio
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships in the form of long-term contracts ranging from three to five years.
QRHC or SRCL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
QRHC vs. SRCL: Which Stock Is the Better Value Option?
Stericycle (SRCL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 11.63% and 1.55%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Clean Harbors (CLH) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Clean Harbors (CLH) delivered earnings and revenue surprises of 59.48% and 9.89%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Waste Connections (WCN) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Waste Connections (WCN) delivered earnings and revenue surprises of 5.26% and 0.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Stericycle (SRCL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Stericycle (SRCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
QRHC vs. SRCL: Which Stock Is the Better Value Option?
by Zacks Equity Research
QRHC vs. SRCL: Which Stock Is the Better Value Option?
QRHC vs. SRCL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
QRHC vs. SRCL: Which Stock Is the Better Value Option?
QRHC vs. SRCL: Which Stock Is the Better Value Option?
by Zacks Equity Research
QRHC vs. SRCL: Which Stock Is the Better Value Option?
Reasons to Retain Stericycle (SRCL) Stock in Your Portfolio
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships in the form of long-term contracts ranging from three to five years.
QRHC vs. SRCL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
QRHC vs. SRCL: Which Stock Is the Better Value Option?
Stericycle (SRCL) Q1 Earnings Miss Estimates, Decrease Y/Y
by Zacks Equity Research
Stericycle's (SRCL) first-quarter 2022 earnings fall year over year due to higher supply chain, labor and other inflationary costs.
Stericycle (SRCL) Gains 3.2% Despite Missing on Q4 Earnings
by Zacks Equity Research
Stericycle's (SRCL) fourth-quarter 2021 earnings decline year over year.
Stericycle (SRCL) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of -13.64% and 0.37%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?